Follow The Filings

MANE Veradermics

Veradermics earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 10 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by MANE's executives, directors and 10% owners in the last 12 months, from their Form 4s

All MANE insider trades
  • $54.1M bought by 5 insiders
  • $91.1M sold by 2 insiders outside a trading plan
  • $12M sold by 2 insiders under 10b5-1 plans
  1. Montanova Capital, LLC Director, +3 joint filers
    Sale
    $80.4M 750,000 shares at $107.25 62% of stake
    Traded Aug 19 Filed Aug 21
  2. Timothy August Durso Chief Technical Officer
    Planned sale
    $4.7M 43,500 shares at $107.82 36% of stake
    Traded Aug 17 Filed Aug 18
  3. Reid Alexander Waldman CEO
    Planned sale
    $7.3M 67,500 shares at $107.86 28% of stake
    Traded Aug 17 Filed Aug 18
  4. John W Childs Director
    Sale
    $10.7M 100,000 shares at $107.12 34% of stake
    Traded Aug 12 Filed Aug 14
  5. John W Childs Director
    Buy
    $5M 294,117 shares at $17.00 New stake
    Traded Feb 5 Filed Feb 27
  6. Suvretta Capital Management, LLC Director, +3 joint filers
    Buy
    $10.5M 282,674 shares at $37.30 +119% to stake
    Traded Feb 4–6 Filed Feb 9
  7. Vlad Coric Director
    Buy
    $2M 117,646 shares at $17.00 +58% to stake
    Traded Feb 5 Filed Feb 5
  8. Longitude Capital Partners V, LLC 10% owner, +3 joint filers
    Buy
    $18.3M 1,075,000 shares at $17.00 +110% to stake
    Traded Feb 5 Filed Feb 5

Also filed in the last 12 months, not counted as buying or selling: 19 conversions, 4 option exercises, and 1 stock grant.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 7.01,8.01,9.01
SCHEDULE 13G —
SCHEDULE 13D/A —
SCHEDULE 13D/A —
424B3
8-K 2.02,9.01
10-Q
S-1
SCHEDULE 13G —
8-K 7.01,8.01,9.01
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
SCHEDULE 13G —
SCHEDULE 13D —
SCHEDULE 13D/A —
SCHEDULE 13D/A —
8-K 1.01,3.02,9.01
424B4 424B3
8-K 7.01,8.01,9.01
8-K 2.02
S-1
8-K 2.02,9.01
10-K
SCHEDULE 13G —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.